Quinidine‐Induced Early Afterdepolarizations and Triggered Activity

1989; Wiley; Volume: 3; Issue: 5 Linguagem: Inglês

10.1111/j.1540-8167.1989.tb01571.x

ISSN

2374-8427

Autores

Charles Antzelevitch, Jorge M. Davidenko, Serge Sicouri, Lawrence B. Cohen, A.A. Iodice, Robert J. Goodrow, Gary Gintant,

Tópico(s)

Neuroscience and Neuropharmacology Research

Resumo

Journal of ElectrophysiologyVolume 3, Issue 5 p. 323-338 Quinidine-Induced Early Afterdepolarizations and Triggered Activity CHARLES ANTZELEVITCH, Corresponding Author CHARLES ANTZELEVITCH Masonic Medical Research Laboratory, Utica, New YorkAddress for correspondence: Charles Antzelevitch, M.D., Masonic Medical Research Laboratory, 2150 Bleecker St., Utica, NY 13504.Search for more papers by this authorJORGE M. DAVIDENKO, JORGE M. DAVIDENKO Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorSERGE SICOURI, SERGE SICOURI Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorLAWRENCE COHEN, LAWRENCE COHEN Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorARTHUR IODICE, ARTHUR IODICE Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorROBERT GOODROW, ROBERT GOODROW Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorGARY A. GINTANT, GARY A. GINTANT Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this author CHARLES ANTZELEVITCH, Corresponding Author CHARLES ANTZELEVITCH Masonic Medical Research Laboratory, Utica, New YorkAddress for correspondence: Charles Antzelevitch, M.D., Masonic Medical Research Laboratory, 2150 Bleecker St., Utica, NY 13504.Search for more papers by this authorJORGE M. DAVIDENKO, JORGE M. DAVIDENKO Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorSERGE SICOURI, SERGE SICOURI Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorLAWRENCE COHEN, LAWRENCE COHEN Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorARTHUR IODICE, ARTHUR IODICE Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorROBERT GOODROW, ROBERT GOODROW Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this authorGARY A. GINTANT, GARY A. GINTANT Masonic Medical Research Laboratory, Utica, New YorkSearch for more papers by this author First published: October 1989 https://doi.org/10.1111/j.1540-8167.1989.tb01571.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Moe B, Davidenko JM, Antzelevitch C: Quinidine-induced triggered activity. Effect of magnesium. (abstract) Fed Proc 44: 899, 1985. Web of Science®Google Scholar 2 Roden DM, Hoffman BF: Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje Fibers. Circ Res, 56: 857, 1985. 10.1161/01.RES.56.6.857 CASPubMedWeb of Science®Google Scholar 3 Bauman JL, Bauernfeind RA, Hoff JV, et al.: Torsade de pointes due to quinidine: observations in 31 patients. Am Heart J, 107: 425, 1984. 10.1016/0002-8703(84)90081-4 CASPubMedWeb of Science®Google Scholar 4 Krikler DM, Curry PVL: Torsade de pointes: an atypical ventricular tachycardia. Br Heart J, 38: 117, 1976. 10.1136/hrt.38.2.117 PubMedWeb of Science®Google Scholar 5 Tzivoni D, Keren A, Stern S, et al.: Disopyramide-induced torsade de pointes. Arch Intern Med, 141: 946, 1981. CASPubMedWeb of Science®Google Scholar 6 Stratmann HG, Walter KE, Kennedy HL: Torsade de pointes associated with elevated N-acetyl-procainamide levels. Am Heart J, 109: 375, 1985. 10.1016/0002-8703(85)90615-5 CASPubMedWeb of Science®Google Scholar 7 Brachmann J, Scherlag BJ, Rozenshtraukh LV et al.: Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation, 68: 846, 1983. 10.1161/01.CIR.68.4.846 CASPubMedWeb of Science®Google Scholar 8 Roden DM, Woosley RL: Bradycardia-dependent triggered arrhythmias in the intact heart, (abstract) J Am Coll Cardiol 5: 390, 1985. Web of Science®Google Scholar 9 Tzivoni D, Keren A, Cohen AM, et al.: Magnesium therapy for torsades de pointes. Am J Cardiol, 53: 528, 1984. 10.1016/0002-9149(84)90025-0 PubMedWeb of Science®Google Scholar 10 Halkin H, Vered Z, Millman P, et al.: Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction. Isr J Med Sci, 15: 583, 1979. CASPubMedWeb of Science®Google Scholar 11 Henning R, Nyberg H: Serum quinidine level after administration of three different quinidine preparations. Eur J Clin Pharmacol, 6: 239, 1973. 10.1007/BF00644739 CASPubMedWeb of Science®Google Scholar 12 Baker BJ, Gammul J, Massengill J, et al.: Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects. Am Heart J, 105: 12, 1983. 10.1016/0002-8703(83)90271-5 CASPubMedWeb of Science®Google Scholar 13 Guentert TW, Oie S: Factors influencing the apparent protein binding of quinidine. J Pharm Sci, 71: 325, 1982. 10.1002/jps.2600710316 CASPubMedWeb of Science®Google Scholar 14 Shen XT, Antzelevitch C: Mechanisms underlying the antiarrhythmic and arrhythmogenic actions of quinidine in a Purkinje fiber-ischemic gap preparation of reflected reentry. Circulation, 73: 1342, 1986. 10.1161/01.CIR.73.6.1342 CASPubMedWeb of Science®Google Scholar 15 Gough B, Hu D, El-Sherif N: Effects of dofilium on ischemic subendocardial Purkinje fibers 1 day postinfarction. J Am Coll Cardiol, 11: 431, 1988. 10.1016/0735-1097(88)90112-X CASPubMedWeb of Science®Google Scholar 16 Damiano BP, Rosen MR: Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation, 69: 1013, 1984. 10.1161/01.CIR.69.5.1013 CASPubMedWeb of Science®Google Scholar 17 Mendez C, Delmar M: Triggered activity: its possible role in cardiac arrhythmias. In DP Zipes, J Jalife (eds): Cardiac Electrophysiotogy and Arrhythmias. Grune & Stratton, Orlando , FL , 1984, pp 311–313. Google Scholar 18 Colatsky T: Mechanisms of action of lidocaine and quinidine on action potential duration of rabbit cardiac Purkinje fibers. Circ Res, 50: 17, 1982. 10.1161/01.RES.50.1.17 CASPubMedWeb of Science®Google Scholar 19 Carmeliet E, Saikawa T: Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine and procainamide in sheep cardiac Purkinje fibers. Circ Res, 50: 257, 1982. 10.1161/01.RES.50.2.257 CASPubMedWeb of Science®Google Scholar 20 Lee KS, Hime JR, Giles W, et al.: Sodium depression by lidocaine and quinidine in isolated ventricular cells. Nature, 291: 325, 1981. 10.1038/291325a0 CASPubMedWeb of Science®Google Scholar 21 Ducouret P: The effect of quinidine on membrane electrical activity in frog auricular fibers studied by current and voltage clamp. Br J Pharmacol, 57: 455, 1976. 10.1111/j.1476-5381.1976.tb07465.x Google Scholar 22 Imaizumi Y, Giles WR: Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol, 253: 704, 1987. 10.1152/ajpheart.1987.253.3.H704 CASPubMedWeb of Science®Google Scholar 23 Salata JJ, Wasserstron JA: Effects of quinidine on action potentials and ionic currents in isolated canine ventricular myocytes. Circ Res, 62: 324, 1988. 10.1161/01.RES.62.2.324 CASPubMedWeb of Science®Google Scholar 24 Coulombe A, Coraboeuf E, Malecot C, et al.: Role of the Na window current and other ionic currents in triggering early after depolarizations and resulting re-excitations in Purkinje fibers. In DP Zipes, J Jalife (eds): Cardiac Electrophysiology and Arrhythmias. Grune & Stratton, Orlando , FL , 1984, pp. 43–49. Google Scholar 25 Coraboeuf E, Deroubaix E, Coulombe A: Acidosis induced abnormal repolarization and repetitive activity in isolated dog Purkinje fibers. J Physiol (Paris) 76: 97, 1980. CASPubMedWeb of Science®Google Scholar 26 Nattel S, Bailey JC: Time course of electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide. J Pharmacol Exper Ther, 225: 176, 1983. CASPubMedWeb of Science®Google Scholar 27 Hondeghem LM, Katzung BG: Time and voltage-dependent interaction of antiarrhythmic drugs with the cardiac sodium channel. Biochim Biophys Acta, 472: 373, 1977. 10.1016/0304-4157(77)90003-X CASPubMedWeb of Science®Google Scholar 28 Grant AO, Starmer CF, Strauss HC: Antiar-rhythmic drug action. Blockade of the inward sodium current. Circ Res, 55: 427, 1984. 10.1161/01.RES.55.4.427 CASPubMedWeb of Science®Google Scholar 29 Weld FM, Coromilas J, Rottman JN, et al.: Mechanisms of quinidine-induced depression of maximum upstroke velocity in bovine cardiac Purkinje fibers. Circ Res, 50: 369, 1982. 10.1161/01.RES.50.3.369 CASPubMedWeb of Science®Google Scholar 30 Roden DM, Bennett PB, Hondeghem LM: Quinidine blocks cardiac potassium channels in a time- and voltage-dependent fashion, (abstract) Biophys J 49: 352a, 1986. Google Scholar 31 Attwell D, Cohen I, Eisner D, et al.: The steady state TTX-sensitive window sodium current in car-diac Purkinje fibers. Pfluegers Arch, 379: 137, 1979. 10.1007/BF00586939 CASPubMedWeb of Science®Google Scholar 32 Gintant GA, Datyner NB, Cohen IS: Slow inactivation of a tetrodotoxin-sensitive current in canine cardiac Purkinje fibers. Biophys J, 45: 509, 1984. 10.1016/S0006-3495(84)84187-9 CASPubMedWeb of Science®Google Scholar 33 Gadsby DC, Cranefield PF: Direct measurement of changes in sodium pump current in canine car-diac Purkinje fibers. Proc Natl Acad Sci USA, 76: 783, 1979. 10.1073/pnas.76.4.1783 Web of Science®Google Scholar 34 Noble D: Ionic bases of rhythmic activity in the heart. In DP Zipes, J Jalife (eds): Cardiac Electrophysiology and Arrhythmias, Grune & Stratton, Inc. Orlando FL , 1984. Google Scholar 35 Kleinfield ME, Stein E, Aguillardo D: Divalent cations on action potentials of dog heart. Am J Physiol, 211: 1438, 1966. PubMedWeb of Science®Google Scholar 36 Shine KI, Douglas AM: Magnesium effects on ionic exchange and mechanical function in rat ventricle. Am J Physiol, 227: 317, 1974. CASPubMedWeb of Science®Google Scholar 37 Sebeszta M, Coraboeuf E, Deroubaix E, et al.: Effect of tetraethylammonium, 4-aminopyridine, cesium and magnesium on slow responses in the guinea pig papillary muscle. Cardiovasc Res, 15: 468, 1981. 10.1093/cvr/15.8.468 CASPubMedWeb of Science®Google Scholar 38 Del Castillo J, Engbaek L: The nature of neuromuscular block produced by magnesium. J Physiol, 124: 370, 1941. 10.1113/jphysiol.1954.sp005114 Google Scholar 39 Frankenhauser B, Hodgkin AL: The action of calcium on the electrical properties of squid axon. J Physiol (Lond) 137: 218, 1957. 10.1113/jphysiol.1957.sp005808 PubMedWeb of Science®Google Scholar 40 Weidmann S: Effects of calcium ions and local anaesthetics on electrical properties of Purkinje fibers. J Physiol (Lond) 129: 568, 1955. 10.1113/jphysiol.1955.sp005379 CASPubMedWeb of Science®Google Scholar 41 Chesnais JM, Coraboeuf E, Sauviat MP, et al.: Sensitivity to H, Li and Mg ions of the slow inward current in frog atrial fibres. J Mol Cell Cardiol, 7: 627, 1975. 10.1016/0022-2828(75)90140-6 CASPubMedWeb of Science®Google Scholar 42 Vetulli H, Antzelevitch C: Quinidine induced early afterdepolarizations, triggered activity and dispersion of refractoriness in canine Purkinje-muscle preparations, (abstract) X World Congress of Cardiology, Washington DC, September, 1986. Google Scholar 43 Neff MS, Mendelssohn S, Kim KE, et al.: Magnesium sulfate in digitalis toxicity. Am J Cardiol, 29: 377, 1972. 10.1016/0002-9149(72)90534-6 CASPubMedWeb of Science®Google Scholar 44 Seller RH: The role of magnesium in digitalis toxicity. Am Heart J, 82: 551, 1971. 10.1016/0002-8703(71)90242-0 CASPubMedWeb of Science®Google Scholar 45 Harris AS, Estandia A, Smith HT, et al.: Magnesium sulfate and chloride in suppression of ectopic ventricular tachycardia accompanying acute myocardial infarction. Am J Physiol, 172: 251, 1953. CASPubMedWeb of Science®Google Scholar 46 Sullivan JF, Wolpert PW, Williams R, et al.: Serum magnesium in chronic alcoholism. Ann NY Acad Sci, 162: 947, 1969. 10.1111/j.1749-6632.1969.tb13023.x PubMedWeb of Science®Google Scholar 47 Tzivoni D, Banai S, Schuger C, et al.: Treatment of torsade de pointes with magnesium sulfate. Circulation, 77: 392, 1988. 10.1161/01.CIR.77.2.392 CASPubMedWeb of Science®Google Scholar 48 Reiter MJ, Higgins SL, Payne AG, et al.: Effects of quinidine versus procainamide on the QT interval. Am J Cardiol, 58: 512, 1986. 10.1016/0002-9149(86)90025-1 CASPubMedWeb of Science®Google Scholar 49 Velebit V, Podrid P, Lown B, et al.: Aggravation and provocation of ventricular arrhythmias by antiar-rhythmic drugs. Circulation, 65: 886, 1982. 10.1161/01.CIR.65.5.886 CASPubMedWeb of Science®Google Scholar 50 Keren A, Tzivoni D, Gavish D, et al.: Etiology, warning signs and therapy of torsade de pointes. Circulation, 64: 1167, 1981. 10.1161/01.CIR.64.6.1167 PubMedWeb of Science®Google Scholar 51 Roden DM, Woosley RL, Primm RK: Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J, 111: 1088, 1986. 10.1016/0002-8703(86)90010-4 CASPubMedWeb of Science®Google Scholar 52 Kay GN, Plumb VJ, Arciniegas JG, et al.: Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol, 2: 806, 1983. 10.1016/S0735-1097(83)80226-5 CASPubMedWeb of Science®Google Scholar Citing Literature Volume3, Issue5October 1989Pages 323-338 ReferencesRelatedInformation

Referência(s)
Altmetric
PlumX